These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
205 related items for PubMed ID: 1450477
21. Enhanced long-term reduction of plasma leptin concentrations by super-flux polysulfone dialysers. van Tellingen A, Grooteman MP, Schoorl M, ter Wee PM, Bartels PC, Schoorl M, van der Ploeg T, Nubé MJ. Nephrol Dial Transplant; 2004 May; 19(5):1198-203. PubMed ID: 14993491 [Abstract] [Full Text] [Related]
22. Comprehensive evaluation of acute immunological changes induced by cuprophane and polysulfone membranes in a patient on chronic hemodialysis. Patarca R, Perez G, Gonzalez A, Garcia-Morales RO, Gamble R, Klimas N, Fletcher MA. Am J Nephrol; 1992 May; 12(4):274-8. PubMed ID: 1481878 [Abstract] [Full Text] [Related]
23. Normal T lymphocyte function in patients with end-stage renal disease hemodialyzed with 'high-flux' polysulfone membranes. Degiannis D, Czarnecki M, Donati D, Homer L, Eisinger RP, Raska K, Raskova J. Am J Nephrol; 1990 May; 10(4):276-82. PubMed ID: 2240054 [Abstract] [Full Text] [Related]
24. Effect of hemodialysis membrane type on parathyroid hormone removal. Kudlac H, Fielding AM, Williams AJ. Miner Electrolyte Metab; 1994 May; 20(5):245-9. PubMed ID: 7700210 [Abstract] [Full Text] [Related]
25. Leukocyte, platelet and endothelial activation in patients with acute renal failure treated by intermittent hemodialysis. de Sá HM, Freitas LA, Alves VC, Garção MF, Rosa MA, Marques AA. Am J Nephrol; 2001 May; 21(4):264-73. PubMed ID: 11509797 [Abstract] [Full Text] [Related]
26. Ultrafiltration using the polysulfone membrane to reduce the cytokine-inducing activity of contaminated dialysate. Lonnemann G, Schindler R. Clin Nephrol; 1994 Jul; 42 Suppl 1():S37-43. PubMed ID: 7923982 [No Abstract] [Full Text] [Related]
27. [The effect of repeated use of cuprophane and polysulfone dialyzers during hemodialysis on the count of natural killer cells in blood]. Liszka M, Moczulski D, Zukowska-Szczechowska E, Grzeszczak W, Religa Z. Pol Arch Med Wewn; 1997 Mar; 97(3):224-31. PubMed ID: 9333768 [Abstract] [Full Text] [Related]
28. Improved preservation of residual renal function in chronic hemodialysis patients using polysulfone dialyzers. McCarthy JT, Jenson BM, Squillace DP, Williams AW. Am J Kidney Dis; 1997 Apr; 29(4):576-83. PubMed ID: 9100048 [Abstract] [Full Text] [Related]
29. Patient survival and renal recovery in acute renal failure: randomized comparison of cellulose acetate and polysulfone membrane dialyzers. Albright RC, Smelser JM, McCarthy JT, Homburger HA, Bergstralh EJ, Larson TS. Mayo Clin Proc; 2000 Nov; 75(11):1141-7. PubMed ID: 11075743 [Abstract] [Full Text] [Related]
30. Influence of acetate and bicarbonate hemodialysis on the plasma erythropoietin concentration in patients with chronic renal failure. Wiecek A, Franek E, Kokot F, Rudka R. Int J Artif Organs; 1997 Feb; 20(2):108-11. PubMed ID: 9093890 [Abstract] [Full Text] [Related]
31. [Effects of hemodialysis membrane on serum lipid profile of maintenance hemodialysis patients]. Tanaka H, Nishikawa O, Yukawa S, Yoshimoto M, Nishide I. Nihon Jinzo Gakkai Shi; 1999 Jan; 41(1):1-7. PubMed ID: 10077981 [Abstract] [Full Text] [Related]
32. Effect of membrane composition on cytokine production and clinical symptoms during hemodialysis: a crossover study. Singh NP, Bansal R, Thakur A, Kohli R, Bansal RC, Agarwal SK. Ren Fail; 2003 May; 25(3):419-30. PubMed ID: 12803505 [Abstract] [Full Text] [Related]
33. Pulmonary gas exchange during dialysis in patients with obstructive lung disease. Pitcher WD, Diamond SM, Henrich WL. Chest; 1989 Nov; 96(5):1136-41. PubMed ID: 2805844 [Abstract] [Full Text] [Related]
34. [Use of bicarbonate dialysis in patients with terminal renal failure]. Kutsenko AI, Zaruba AIu, Chuĭkin NA, Mal'ginov SV, Kukharchuk VV. Ter Arkh; 1989 Nov; 61(6):97-9. PubMed ID: 2799728 [Abstract] [Full Text] [Related]
35. [Effect of hemodialysis with cuprophane and polysulfone membranes on counts of leukocytes, granulocytes, monocytes, lymphocytes and lymphocyte subsets]. Moczulski D, Zukowska-Szczechowska E, Grzeszczak W, Religa Z, Cichoń R, Szydłowska I. Pol Arch Med Wewn; 1994 Nov; 92(5):400-7. PubMed ID: 7885988 [Abstract] [Full Text] [Related]
36. The effects of reprocessing cuprophane and polysulfone dialyzers on beta 2-microglobulin removal from hemodialysis patients. Petersen J, Moore RM, Kaczmarek RG, Singh B, Yeh I, Hamburger S, Kankam M. Am J Kidney Dis; 1991 Feb; 17(2):174-8. PubMed ID: 1992659 [Abstract] [Full Text] [Related]
37. Induction of cytokines and adhesion molecules in stable hemodialysis patients: is there an effect of membrane material? Hoffmann U, Fischereder M, Marx M, Schweda F, Lang B, Straub RH, Krämer BK. Am J Nephrol; 2003 Feb; 23(6):442-7. PubMed ID: 14583663 [Abstract] [Full Text] [Related]
38. Hemodialysis modality, percentage of body fat, and patient survival. Stosovic M, Stanojevic M, Radovic M, Simic-Ogrizovic S, Lezaic V, Naumovic R, Jovanovic D, Ristic G, Djukanovic L, Marinkovic J. Int J Artif Organs; 2009 Jan; 32(1):20-30. PubMed ID: 19241360 [Abstract] [Full Text] [Related]
39. Ranitidine clearance during hemodialysis with high-flux membrane: comparison of polysulfone and cellulose acetate hemodialyzers. Tsuruoka S, Sugimoto KI, Hayasaka T, Saito T, Fujimura A. Eur J Clin Pharmacol; 2000 Nov; 56(8):581-3. PubMed ID: 11151748 [Abstract] [Full Text] [Related]
40. Aspects of biocompatibility of two different dialysis membranes: cuprophane and polysulfone. Amato M, Salvadori M, Bergesio F, Messeri A, Filimberti E, Morfini M. Int J Artif Organs; 1988 May; 11(3):175-80. PubMed ID: 3261279 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]